USFDA inspects Dr. Reddy’s R&D centre in Hyderabad, Laurus Labs’ Visakhapatnam unit and Sun Pharma’s Dadra facility, Torrent Pharmaceuticals’ oncology unit. Reddy’s, Sun Pharma, Laurus and Torrent did not comment.

U.S. regulator inspects Indian pharma firms

Mkt indices rose in early trade but later gave up gains due to profit-taking & muted US mkt. Sensex fell 214.84 pts to 66,687.07 & Nifty 55.80 pts to 20,040.80. Major gainers: UltraTech Cement, Mahindra & Mahindra, Axis Bank, Wipro, HUL, Sun Pharma, Kotak Mahindra Bank & L&T. Asian mkt mixed, US mkt…

Markets give up early gains; trade lower on profit-taking

Mkt indices up on buying in RIL; gains restricted by FII outflows & mixed global trends. Sensex up 74.43 pts to 66,005.20; Nifty up 26.15 pts to 19,809.55. Gains led by Power Grid, Titan, Sun Pharma, Reliance, HUL, Asian Paints, Tata Motors, Tech Mahindra, Nestle & ITC. Kotak Mahindra, ICICI Bank, I…

Sensex, Nifty climb on buying in Reliance

Equity indices fall in early trade; Sensex declines 216.73 points, Nifty slips 63.05 points; ICICI Bank, Power Grid, HDFC Bank, Bharti Airtel, Asian Paints, and Larsen & Toubro major laggards. Bajaj Finserv, IndusInd Bank, Bajaj Finance & Sun Pharma major gainers

Markets decline in early trade after three days of rally

Sanjiv Bhasin, Director, IIFL Securities discussed the pharmaceutical sector, highlighting Lupin as a dark horse with strong growth potential. He also recommended Cipla, Dr. Reddy, Sun Pharma, and Divis for a diversified pharma portfolio. In the small-cap segment, he suggested Idea and TTML as good investments and mentioned Devyani International as a potential outperformer. However, he refrained from commenting on Naica's earnings and remained silent on Mama Earth and ASK IPOs, for which his company is involved as a merchant banker.

#sanjivbhasin #nikunjdalmia #etnow #stocknews #sanjivbhasinlatest #stockmarkets #sanjivbhasintrading #stockinnews #stocks
Subscribe To ET Now For Latest Updates On Stocks, Business News, Trading | https://bit.ly/SubscribeToETNow

To Stay Updated Download the Times Now App :-
Android Google Play :  https://goo.gl/zJhWjC
Apple App Store :  https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

Subscribe Now To Our Network Channels:-
Times Now: https://bit.ly/SubscribeToTimesNow
Mirror Now: https://bit.ly/SubscribeToMirrorNow

Pushed via Slike

Sanjiv Bhasin's Pharma Sector Analysis And Small-Cap Investment Recommendations

Equity indices surge in early trade; Sensex up 414 pts, Nifty at 19,258. Tata Motors, Tech Mahindra, ICICI Bank, Titan, Mahindra & Mahindra, Sun Pharma gain. Global markets, Brent crude up; U.S. S&P rises 1.9%. FIIs offload equities worth ₹1,261.19 crore. Sensex up 0.77%, Nifty 0.76% on Thursday.

Markets continue to rally on positive global trends

IndusInd Bank, Tata Steel, Tata Motors, Sun Pharma, Infosys, Mahindra & Mahindra, Infosys, NTPC, Bharti Airtel, HCL Technologies and Axis Bank were the biggest gainers.

Stock markets rebound after two days of fall amid global rally

Mkts decline 2nd day on Fed rate decision; Sensex down 283 pts, Nifty 90 pts. GST collections at ₹1.72 lakh cr, Oct PMI at slowest rate in yr. Asian mkts mixed, Europe & US in green. FIIs offloaded equities worth ₹696.02 cr. Sun Pharma, Bajaj Finserv, Reliance, SBI & Airtel gainers; Asian Paints, Ta…

Markets fall for 2nd day on foreign fund outflows

Sun Pharma Q2 Results: Net Profit Rises 5% YoY To Rs 2,375 Crore, Sales Up 11%, its Ebitda, including other operating revenues, was up 7.5 per cent to Rs 3,179.4 crore

Sun Pharma Q2 Results: Net Profit Rises 5% YoY To Rs 2,375 Crore, Sales Up 11% - News18

Here are the stocks to watch before going into trade today.

Stocks To Watch: Bharti Airtel, L&T, Sun Pharma, Tata Steel, ITC, Adani Ports, Lupin, Tata Consumer, NBCC

Here are the earnings estimates of major companies that are scheduled to announce their results on Wednesday.

Sun Pharmaceutical, Tata Steel, Britannia Q2 Results Today — Earnings Estimates

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced and in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Not a good time to consider, stock is in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Sun Pharmaceutical Industries Limited is a pharmaceuticals company which offers generics, branded generics, specialty products, over-the-counter products, anti-retroviral and APIs.